Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review

Narrative Review: Statin-Related Myopathy

(2013) Tisha R. Joy   ANNALS OF INTERNAL MEDICINE

Does Reduced Creatine Synthesis Protect against Statin Myopathy?

(2013) Kevin D. Ballard et al.   Cell Metabolism

Statin therapy correlated CYP2D6 gene polymorphism and hyperlipidemia

(2013) Juyi Li et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications

(2013) Rebecca Schnepf et al.   Expert Opinion on Drug Metabolism & Toxicology

Gene–Gene–Environment Interactions Between Drugs, Transporters, Receptors, and Metabolizing Enzymes: Statins, SLCO1B1, and CYP3A4 as an Example

(2013) Wolfgang Sadee   JOURNAL OF PHARMACEUTICAL SCIENCES

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy

(2013) Lara M. Mangravite et al.   NATURE

Estimating heritability in pharmacogenetic studies

(2013) Scott L Marshall et al.   PHARMACOGENOMICS

Practical limitations to estimating heritability in pharmacogenetic studies

(2013) Kijoung Song et al.   PHARMACOGENOMICS

CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are Determinants of Inter-subject Variability in Fluvastatin Pharmacokinetics in Healthy Chinese Volunteers

(2012) Q. Zhou et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

(2012) R A Wilke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects

(2012) Ophelia Qi Ping Yin et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users

(2012) Jerome D. Cohen et al.   Journal of Clinical Lipidology

Statins for people at low risk of cardiovascular disease – Authors' reply

(2012) Borislava Mihaylova et al.   LANCET

SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia

(2011) Paulo Caleb Junior Lima Santos et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Medication Adherence: WHO Cares?

(2011) Marie T. Brown et al.   MAYO CLINIC PROCEEDINGS

Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy

(2011) Amy Egan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

(2011) Kristin D. Marciante et al.   Pharmacogenetics and Genomics

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin

(2011) L R Brunham et al.   PHARMACOGENOMICS JOURNAL

Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis

(2010) Devin M Mann et al.   ANNALS OF PHARMACOTHERAPY

Genetic involvement in statins induced myopathy. Preliminary data from an observational case–control study

(2010) Luca Puccetti et al.   ATHEROSCLEROSIS

Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study

(2010) L A Donnelly et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Approach to the Patient Who Is Intolerant of Statin Therapy

(2010) Robert H. Eckel   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

PharmGKB very important pharmacogene: SLCO1B1

(2010) Connie Oshiro et al.   Pharmacogenetics and Genomics

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

(2010) D Wang et al.   PHARMACOGENOMICS JOURNAL

The genetics of statin-induced myopathy

(2009) Abhijit Ghatak et al.   ATHEROSCLEROSIS

No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin

(2009) Jenni E. Keskitalo et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetic Variations of the SLCO1B1 Gene in the Chinese, Malay and Indian Populations of Singapore

(2009) Woon Fei Ho et al.   Drug Metabolism and Pharmacokinetics

The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects

(2009) Deepak Voora et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

(2009) Jenni E Keskitalo et al.   PHARMACOGENOMICS

The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials

(2008) K. Josan et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin

(2008) JE Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations

(2008) Jessica Mwinyi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy

(2008) Philippe Couvert et al.   PHARMACOGENOMICS

Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin

(2008) J.-E. Park et al.   XENOBIOTICA

Cytochrome P450 and Chemical Toxicology

(2007) F. Peter Guengerich   CHEMICAL RESEARCH IN TOXICOLOGY